Kathleen K. Schoemaker is 10% at Orexigen Therapeutics, Inc. (OREX). They have made 41 open-market trades across 16 companies since 2006, most recently 2015-05-04.
CIK 0001207789
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
25 open-market purchases totalling $107.8M since 2006, against 16 sales. Across 7 scored buys the stock is down 2.2% at ninety days, and 2.5 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 14% | 14% |
| Avg Move | -27.5% | -2.2% | -2.2% |
| Alpha | -21.7% | -2.5% | -2.5% |
| Scored | 7 | 7 | 7 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 60% | 60% |
| Avg Move | -20.7% | -1.2% | -1.2% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TBRA | BUY | 2015-05-04 | 2015-05-06 | $10.62 | $2.9M | -27.9% | +4.0% | +4.0% |
| ATRA | BUY | 2014-10-21 | 2014-10-21 | $11.00 | $2.7M | -24.2% | -6.6% | -6.6% |
| ALIM | SELL · 10b5-1 | 2014-01-15 | 2014-01-17 | $6.39 | $21K | -20.2% | +0.0% | +0.0% |
| RGDO | BUY | 2013-08-27 | 2013-08-28 | $4.00 | $3.0M | N/A | N/A | N/A |
| OCRX | BUY | 2013-07-15 | 2013-07-31 | $6.03 | $8.0M | N/A | N/A | N/A |
| ESPR | BUY | 2013-07-01 | 2013-07-02 | $14.00 | $4.0M | -35.3% | -0.8% | -0.8% |
| ALIM | SELL · 10b5-1 | 2013-06-20 | 2013-06-24 | $5.01 | $53K | -20.2% | +0.0% | +0.0% |
| ALIM | SELL · 10b5-1 | 2013-06-18 | 2013-06-20 | $5.39 | $3K | -20.2% | +0.0% | +0.0% |
| CLVS | SELL | 2013-06-04 | 2013-06-05 | $64.58 | $179K | -29.4% | -2.5% | -2.5% |
| ALIM | SELL | 2013-05-15 | 2013-05-17 | $4.60 | $2K | -20.2% | +0.0% | +0.0% |
| CADX | SELL · 10b5-1 | 2013-03-21 | 2013-03-22 | $5.49 | $10K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-15 | 2013-03-19 | $5.23 | $92K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-11 | 2013-03-13 | $5.36 | $949 | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-11 | 2013-03-13 | $5.36 | $173K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-07 | 2013-03-11 | $5.25 | $289K | N/A | N/A | N/A |
| CLVS | SELL | 2013-03-04 | 2013-03-06 | $24.59 | $6.1M | -29.4% | -2.5% | -2.5% |
| CADX | SELL · 10b5-1 | 2013-03-01 | 2013-03-05 | $5.01 | $1K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-01 | 2013-03-05 | $5.01 | $2K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-01 | 2013-02-05 | $4.85 | $146K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-01 | 2013-02-05 | $4.85 | $795 | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-01-30 | 2013-02-01 | $4.82 | $440K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-01-22 | 2013-01-24 | $5.08 | $7K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-01-22 | 2013-01-24 | $5.08 | $631K | N/A | N/A | N/A |
| DRTX | BUY | 2012-07-24 | 2012-07-24 | $9.00 | $7.1M | N/A | N/A | N/A |
| RVA | SELL | 2012-03-23 | 2012-03-27 | $5.16 | $8.7M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ZGNX | 169,251 | $4.5M |
| ALDX | 1,973,389 | $1.4M |
| ACHN | 159,896 | $1.1M |
| AKAO | 1,987,049 | $219K |
| EVOK | 19,006 | $209K |
| ALIM | 37,137 | $206K |
| OTIC | 1,579,323 | $122K |
| CLVS | 44,034 | $4K |
| OCRX | 1,857,036 | — |
| OREX | 50,643 | — |
| RGDO | 2,571,117 | — |
| RVA | 85,186 | — |
| SENO | 24,665 | — |
| SOMX | 15,456 | — |
| DRTX | 22,306 | — |
| CADX | 78,369 | — |
| VOLC | 14,782 | — |
| NEOT | 46,309 | — |
| IOMI | 1,699,794 | — |
| NOVC | 3,054,396 | — |
| NSTR | 2,068,500 | — |
| Total | $440.8M |
Shares reported on the most recent Form 4, priced at the 2015-05-06 close. 13 holdings could not be priced and are excluded from the total.
| Scored | 5 | 5 | 5 |